Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/41/ef/d2/41efd20b-6718-7531-e925-ec45b2a2ebfd/mza_8690899621189754337.jpeg/600x600bb.jpg
Oncology for the Inquisitive Mind
Michael Fernando and Josh Hurwitz
199 episodes
1 day ago
Cancer is a fascinating but rapidly evolving discipline - it's a full-time job just keeping up to date. In this podcast, Dr Michael Fernando and Dr Joshua Hurwitz explore the latest trials, research, and practice-changing updates, as well as regular interviews with renowned oncology specialists. Ideal for those starting their training journey, established specialists and anyone interested in medical science, oncological practice, or terrible jokes. Preferably all three.

Hosted on Acast. See acast.com/privacy for more information.

Show more...
Medicine
Education,
Health & Fitness,
Science,
Life Sciences
RSS
All content for Oncology for the Inquisitive Mind is the property of Michael Fernando and Josh Hurwitz and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Cancer is a fascinating but rapidly evolving discipline - it's a full-time job just keeping up to date. In this podcast, Dr Michael Fernando and Dr Joshua Hurwitz explore the latest trials, research, and practice-changing updates, as well as regular interviews with renowned oncology specialists. Ideal for those starting their training journey, established specialists and anyone interested in medical science, oncological practice, or terrible jokes. Preferably all three.

Hosted on Acast. See acast.com/privacy for more information.

Show more...
Medicine
Education,
Health & Fitness,
Science,
Life Sciences
https://assets.pippa.io/shows/62d20dbcffef490011c8df4b/1687335645290-dded42fc0e53bbaf3d3033807982d557.jpeg
178. Back to Basics - Metastatic Non Small Cell Lung Cancer (mNSCLCa)
Oncology for the Inquisitive Mind
19 minutes 22 seconds
1 month ago
178. Back to Basics - Metastatic Non Small Cell Lung Cancer (mNSCLCa)

Advanced or Metastatic Non Small Cell Lung Cancer (mNSCLCa), is one of the most common causes of death worldwide. This week, Michael provides an excellent background on this type of cancer, and Josh provides an eloquently short introduction (for once). These trials look specifically at lung cancers without mutations, thus relying on immunotherapy and chemotherapy.


As a side note, can you believe Keynote189 is over 7 years old! How time flies!


Studies discussed in this episode:

Keynote 189

Checkmate 9LA


For more episodes, resources and blog posts, visit www.inquisitiveonc.com

Please find us on Twitter @InquisitiveOnc!

If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


Art courtesy of Taryn Silver

Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/


Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.


Hosted on Acast. See acast.com/privacy for more information.

Oncology for the Inquisitive Mind
Cancer is a fascinating but rapidly evolving discipline - it's a full-time job just keeping up to date. In this podcast, Dr Michael Fernando and Dr Joshua Hurwitz explore the latest trials, research, and practice-changing updates, as well as regular interviews with renowned oncology specialists. Ideal for those starting their training journey, established specialists and anyone interested in medical science, oncological practice, or terrible jokes. Preferably all three.

Hosted on Acast. See acast.com/privacy for more information.